The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.
Myxoma virus (MYXV) induces a lethal disease called Myxomatosis in European rabbits. MYXV is one of the rare viruses that encodes an α2,3-sialyltransferase through its M138L gene. In this study, we showed that although the absence of the enzyme was not associated with any in vitro deficit, the M138L...
Saved in:
| Main Authors: | Bérengère Boutard, Sophie Vankerckhove, Nicolas Markine-Goriaynoff, Mickaël Sarlet, Daniel Desmecht, Grant McFadden, Alain Vanderplasschen, Laurent Gillet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0118806&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma
by: Yuli Jian, et al.
Published: (2025-02-01) -
Sialyltransferase-related genes as predictive factors for therapeutic response and prognosis in cervical cancer
by: Jia Shao, et al.
Published: (2025-05-01) -
Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in E. coli
by: Anuj Kumar Gupta, et al.
Published: (2015-01-01) -
Sialyltransferase gene signature as a predictor of prognosis and therapeutic response in kidney renal clear cell carcinoma
by: Huiyu Liu, et al.
Published: (2025-05-01) -
Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.
by: Franz J Zemp, et al.
Published: (2013-01-01)